Book Navigation

Editor’s Picks

The following literature has been added to our library recently. For a good read, see the following Editors Picks

    • Authors
      Langer G, Meerpohl JJ, Perleth M, Gartlehner G, Kaminski-Hartenthaler A, Schunemann H.
    • Title
      [GRADE guidelines: 2. Framing the question and deciding on important outcomes]. [German]
    • Abstract
      GRADE requires a clear specification of the relevant setting, population, intervention, and comparator. It also requiresspecification of all important outcomes - whether evidence from research studies is, or is not, available. For a particular management question, the population, intervention, and outcome should be sufficiently similar across studies so that a similar magnitude of effect is plausible. Guideline developers should specify the relative importance of the outcomes before gathering the evidence and again when evidence summaries are complete. In considering the importance of a surrogate outcome, authors should rate the importance of the patient-important outcome for which the surrogate is a substitute and subsequently rate down the quality of evidence for indirectness of outcome. Copyright Copyright 2012. Published by Elsevier GmbH.
    • Authors
      Zhao D, Hu D.
    • Title
      Barriers to translating EU and US CVD guidelines into practice in China.
    • Abstract
      With the increasing globalization of clinical research and evidence, clinical-practice guidelines (CPGs) developed by the European Union (EU) and the USA are also becoming increasingly international. However, these CPGs can encounter barriers to their practical application. In this Perspectives article, we analyze the main obstacles to the application of EU and US CPGs for cardiovascular diseases from the unique perspective of China, and highlight some potential problems in the globalization of CPGs. Currently, China and other countries with limited independent evidence for CPG development must localize or adapt the CPGs developed by the EU, the USA, or international medical organizations, with systematic consideration of costeffectiveness and alternative strategies on the basis of the available evidence from the native populations. At the same time, comprehensive capabilities to collect and review clinical evidence to produce population-specific CPGs should be developed.


    Page last updated: Dec 14, 2012
    Copyright © 2002-2016 Guidelines International Network.
    All rights reserved

    The Guidelines International Network is formally constituted as a Scottish Guarantee Company under Company Number SC243691 and recognised as a Scottish Charity under Scottish Charity Number SC034047 with its Registered Office at J. & H. Mitchell W.S., 51 Atholl Road, Pitlochry, Perthshire PH16 5BU, Scotland.

    Back to top